Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs/symptoms of pneumonia. Immunosuppressed.

Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type ...

It doesn’t come in a generic version. However, there are other different inhaled versions of the active ingredient found in Spiriva that are available as a generic. A generic drug is an exact ...

Ipratropium bromide 20mcg, albuterol 100mcg (equivalent to 120mcg albuterol sulfate); per actuation; inhalation spray; CFC-free. Based on studies, ipratropium bromide appears to inhibit vagally ...

Drug companies are taking advantage of a global climate treaty to boost profits. The treaty, signed by some 120 countries nearly a decade ago, is now providing inhaler makers with a golden escape ...

at § 355(b)(1)(A)(viii). Teva’s Inhaler Patents relate generally to an inhaler device for delivering the drug. More specifically, the patents claim metered dose inhaler dose counters ...

Purpose: The effects of extreme temperatures on drug delivery of two albuterol sulfate hydrofluoroalkane, metered-dose inhalers (MDIs) were evaluated.Methods. Three Proventil HFA and three ...

The inhalation and nasal spray generic drugs market has experienced robust growth in recent years, expanding from $28.01 billion in 2023 to $30.06 billion in 2024 at a compound annual growth rate ...

GSK plc GSK reported third-quarter 2024 core earnings of $1.27 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.16. Core earnings declined 1% year over year on a ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...